Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study

DOI record: { "DOI": "10.1016/j.jinf.2025.106510", "ISSN": [ "0163-4453" ], "URL": "http://dx.doi.org/10.1016/j.jinf.2025.106510", "alternative-id": [ "S0163445325001045" ], "article-number": "106510", "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study" }, { "label": "Journal Title", "name": "journaltitle", "value": "Journal of Infection" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.jinf.2025.106510" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2025 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association." } ], "author": [ { "affiliation": [], "family": "Breuer", "given": "Judith", "sequence": "first" }, { "affiliation": [], "family": "Drysdale", "given": "Myriam", "sequence": "additional" }, { "affiliation": [], "family": "Walker", "given": "Jill", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-4744-8067", "affiliation": [], "authenticated-orcid": false, "family": "Han", "given": "Jennifer", "sequence": "additional" }, { "affiliation": [], "family": "Aylott", "given": "Alicia", "sequence": "additional" }, { "affiliation": [], "family": "Van Dyke", "given": "Melissa K.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-4924-4810", "affiliation": [], "authenticated-orcid": false, "family": "Birch", "given": "Helen J.", "sequence": "additional" }, { "affiliation": [], "family": "McKie", "given": "Elizabeth", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1768-0853", "affiliation": [], "authenticated-orcid": false, "family": "Jordan", "given": "William", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-4651-327X", "affiliation": [], "authenticated-orcid": false, "family": "Gemzoe", "given": "Kim", "sequence": "additional" }, { "affiliation": [], "family": "Gillespie", "given": "Iain A.", "sequence": "additional" }, { "affiliation": [], "family": "Bethune", "given": "Claire", "sequence": "additional" }, { "affiliation": [], "family": "Williams", "given": "Charlotte A.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-6963-2821", "affiliation": [], "authenticated-orcid": false, "family": "Underwood", "given": "Jonathan", "sequence": "additional" }, { "affiliation": [], "family": "Goodman", "given": "Anna L.", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-7205-8947", "affiliation": [], "authenticated-orcid": false, "family": "Brown", "given": "Michael", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-4681-9586", "affiliation": [], "authenticated-orcid": false, "family": "Brown", "given": "Julianne R.", "sequence": "additional" }, { "affiliation": [], "family": "Williams", "given": "Rachel", "sequence": "additional" }, { "affiliation": [], "family": "Bernal", "given": "Luz Marina Martin", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-7404-7800", "affiliation": [], "authenticated-orcid": false, "family": "Buggiotti", "given": "Laura", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-0930-8330", "affiliation": [], "authenticated-orcid": false, "family": "Gkrania-Klotsas", "given": "Effrossyni", "sequence": "additional" }, { "affiliation": [], "family": "Green", "given": "Clara", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0002-1620-7095", "affiliation": [], "authenticated-orcid": false, "family": "Hunter", "given": "Ewan", "sequence": "additional" }, { "ORCID": "https://orcid.org/0009-0000-3427-3734", "affiliation": [], "authenticated-orcid": false, "family": "Miller", "given": "Charles", "sequence": "additional" }, { "affiliation": [], "family": "Skingsley", "given": "Andrew", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0001-6102-2375", "affiliation": [], "authenticated-orcid": false, "family": "Lowe", "given": "David M.", "sequence": "additional" } ], "container-title": "Journal of Infection", "container-title-short": "Journal of Infection", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.com", "journalofinfection.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2025, 5, 19 ] ], "date-time": "2025-05-19T23:36:28Z", "timestamp": 1747697788000 }, "deposited": { "date-parts": [ [ 2025, 5, 25 ] ], "date-time": "2025-05-25T00:20:56Z", "timestamp": 1748132456000 }, "funder": [ { "DOI": "10.13039/100004330", "award": [ "218407" ], "doi-asserted-by": "publisher", "id": [ { "asserted-by": "publisher", "id": "10.13039/100004330", "id-type": "DOI" } ], "name": "GSK" } ], "indexed": { "date-parts": [ [ 2025, 5, 25 ] ], "date-time": "2025-05-25T00:40:06Z", "timestamp": 1748133606432, "version": "3.41.0" }, "is-referenced-by-count": 0, "issue": "1", "issued": { "date-parts": [ [ 2025, 7 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2025, 7 ] ] } }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T00:00:00Z", "timestamp": 1751328000000 } }, { "URL": "https://www.elsevier.com/legal/tdmrep-license", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 7, 1 ] ], "date-time": "2025-07-01T00:00:00Z", "timestamp": 1751328000000 } }, { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 5, 11 ] ], "date-time": "2025-05-11T00:00:00Z", "timestamp": 1746921600000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0163445325001045?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0163445325001045?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "page": "106510", "prefix": "10.1016", "published": { "date-parts": [ [ 2025, 7 ] ] }, "published-print": { "date-parts": [ [ 2025, 7 ] ] }, "publisher": "Elsevier BV", "reference": [ { "key": "#cr-split#-10.1016/j.jinf.2025.106510_bib1.1", "unstructured": "World Health Organization. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic" }, { "key": "#cr-split#-10.1016/j.jinf.2025.106510_bib1.2", "unstructured": "2023. Available at: https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic. Accessed December 12, 2024." }, { "DOI": "10.1093/cid/ciab438", "article-title": "The effectiveness of the two-dose BNT162b2 vaccine: analysis of real-world data", "author": "Chodick", "doi-asserted-by": "crossref", "first-page": "472", "journal-title": "Clin Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib2", "volume": "74", "year": "2022" }, { "DOI": "10.15585/mmwr.mm7044e3", "article-title": "Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021", "author": "Embi", "doi-asserted-by": "crossref", "first-page": "1553", "journal-title": "MMWR Morb Mortal Wkly Rep", "key": "10.1016/j.jinf.2025.106510_bib3", "volume": "70", "year": "2021" }, { "DOI": "10.1016/j.jinf.2021.12.035", "article-title": "Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: a systematic literature review and meta-analysis", "author": "Marra", "doi-asserted-by": "crossref", "first-page": "297", "journal-title": "J Infect", "key": "10.1016/j.jinf.2025.106510_bib4", "volume": "84", "year": "2022" }, { "DOI": "10.1080/13696998.2021.2002063", "article-title": "Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2", "author": "Di Fusco", "doi-asserted-by": "crossref", "first-page": "1248", "journal-title": "J Med Econ", "key": "10.1016/j.jinf.2025.106510_bib5", "volume": "24", "year": "2021" }, { "DOI": "10.1136/bmj.n2244", "article-title": "Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study", "author": "Hippisley-Cox", "doi-asserted-by": "crossref", "first-page": "n2244", "journal-title": "BMJ", "key": "10.1016/j.jinf.2025.106510_bib6", "volume": "374", "year": "2021" }, { "DOI": "10.1093/cid/ciaa1166", "article-title": "Household transmission of severe acute respiratory syndrome coronavirus-2 in the United States", "author": "Lewis", "doi-asserted-by": "crossref", "first-page": "1805", "journal-title": "Clin Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib7", "volume": "73", "year": "2021" }, { "DOI": "10.1126/scitranslmed.adk1599", "article-title": "SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency", "author": "Li", "doi-asserted-by": "crossref", "journal-title": "Sci Transl Med", "key": "10.1016/j.jinf.2025.106510_bib8", "volume": "16", "year": "2024" }, { "DOI": "10.1186/s12879-021-06429-5", "article-title": "Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report", "author": "Niyonkuru", "doi-asserted-by": "crossref", "first-page": "743", "journal-title": "BMC Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib9", "volume": "21", "year": "2021" }, { "DOI": "10.1371/journal.pmed.1002493", "article-title": "Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: a Phase 1 open-label clinical trial in healthy adults", "author": "Gaudinski", "doi-asserted-by": "crossref", "journal-title": "PLoS Med", "key": "10.1016/j.jinf.2025.106510_bib10", "volume": "15", "year": "2018" }, { "DOI": "10.1038/s41586-020-2349-y", "article-title": "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody", "author": "Pinto", "doi-asserted-by": "crossref", "first-page": "290", "journal-title": "Nature", "key": "10.1016/j.jinf.2025.106510_bib11", "volume": "583", "year": "2020" }, { "DOI": "10.1056/NEJMoa2107934", "article-title": "Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab", "author": "Gupta", "doi-asserted-by": "crossref", "first-page": "1941", "journal-title": "N Engl J Med", "key": "10.1016/j.jinf.2025.106510_bib12", "volume": "385", "year": "2021" }, { "DOI": "10.1001/jama.2022.2832", "article-title": "Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial", "author": "Gupta", "doi-asserted-by": "crossref", "first-page": "1236", "journal-title": "JAMA", "key": "10.1016/j.jinf.2025.106510_bib13", "volume": "327", "year": "2022" }, { "DOI": "10.1016/j.cmi.2022.08.021", "article-title": "Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretion", "author": "Andrés", "doi-asserted-by": "crossref", "first-page": "240", "journal-title": "Clin Microbiol Infect", "key": "10.1016/j.jinf.2025.106510_bib14", "volume": "29", "year": "2023" }, { "DOI": "10.1093/cid/ciac601", "article-title": "Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the severe acute respiratory syndrome coronavirus 2 Omicron variant", "author": "Huygens", "doi-asserted-by": "crossref", "first-page": "e507", "journal-title": "Clin Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib15", "volume": "76", "year": "2023" }, { "DOI": "10.1128/aac.00266-23", "article-title": "Frequent emergence of resistance mutations following complex intra-host genomic dynamics in SARS-CoV-2 patients receiving sotrovimab", "author": "Palomino-Cabrera", "doi-asserted-by": "crossref", "journal-title": "Antimicrob Agents Chemother", "key": "10.1016/j.jinf.2025.106510_bib16", "volume": "67", "year": "2023" }, { "DOI": "10.1056/NEJMc2120219", "article-title": "Resistance mutations in SARS-CoV-2 Delta variant after sotrovimab use", "author": "Rockett", "doi-asserted-by": "crossref", "first-page": "1477", "journal-title": "N Engl J Med", "key": "10.1016/j.jinf.2025.106510_bib17", "volume": "386", "year": "2022" }, { "DOI": "10.1016/j.cmi.2022.05.002", "article-title": "Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab", "author": "Vellas", "doi-asserted-by": "crossref", "first-page": "1297", "journal-title": "Clin Microbiol Infect", "key": "10.1016/j.jinf.2025.106510_bib18", "volume": "28", "year": "2022" }, { "key": "10.1016/j.jinf.2025.106510_bib19", "unstructured": "UK Department of Health & Social Care. Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report. Available at: 〈https://www.gov.uk/government/publications/higher-risk-patients-eligible-for-covid-19-treatments-independent-advisory-group-report/defining-the-highest-risk-clinical-subgroups-upon-community-infection-with-sars-cov-2-when-considering-the-use-of-neutralising-monoclonal-antibodies#recommendations〉. Accessed December 12, 2024." }, { "key": "10.1016/j.jinf.2025.106510_bib20", "unstructured": "NHS England. Commissioning Framework: COVID-19 Therapeutics for Non-Hospitalised Patients. Updated 29 March 2023. Available at: https://www.england.nhs.uk/coronavirus/publication/commissioning-framework-covid-19-therapeutics-for-non-hospitalised-patients/. Accessed April 29, 2025." }, { "key": "10.1016/j.jinf.2025.106510_bib21", "unstructured": "European Medicines Agency. Xevudy. Summary of Product Characteristics 2023. Available at: 〈https://www.ema.europa.eu/en/medicines/human/EPAR/xevudy〉. Accessed December 12, 2024." }, { "article-title": "Resistance analysis in the COMET-TAIL study: participants with mild-to-moderate COVID-19 treated with intramuscular or intravenous sotrovimab", "author": "Moya", "journal-title": "Open Forum Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib22", "volume": "9", "year": "2022" }, { "DOI": "10.2217/fvl-2023-0146", "article-title": "Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study", "author": "Subramanian", "doi-asserted-by": "crossref", "first-page": "975", "journal-title": "Future Virol", "key": "10.1016/j.jinf.2025.106510_bib23", "volume": "18", "year": "2023" }, { "DOI": "10.1056/NEJMc2031670", "article-title": "Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer", "author": "Aydillo", "doi-asserted-by": "crossref", "first-page": "2586", "journal-title": "N Engl J Med", "key": "10.1016/j.jinf.2025.106510_bib24", "volume": "383", "year": "2020" }, { "DOI": "10.1001/jama.2024.1014", "article-title": "When it comes to SARS-CoV-2 clearance, people who are immunocompromised are not all alike", "author": "Rubin", "doi-asserted-by": "crossref", "first-page": "723", "journal-title": "JAMA", "key": "10.1016/j.jinf.2025.106510_bib25", "volume": "331", "year": "2024" }, { "DOI": "10.1126/science.adc9127", "article-title": "Imprinted antibody responses against SARS-CoV-2 Omicron sublineages", "author": "Park", "doi-asserted-by": "crossref", "first-page": "619", "journal-title": "Science", "key": "10.1016/j.jinf.2025.106510_bib26", "volume": "378", "year": "2022" }, { "DOI": "10.1038/s41467-022-31615-7", "article-title": "Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains", "author": "Case", "doi-asserted-by": "crossref", "first-page": "3824", "journal-title": "Nat Commun", "key": "10.1016/j.jinf.2025.106510_bib27", "volume": "13", "year": "2022" }, { "DOI": "10.1038/s41586-022-04856-1", "article-title": "Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2", "author": "Uraki", "doi-asserted-by": "crossref", "first-page": "119", "journal-title": "Nature", "key": "10.1016/j.jinf.2025.106510_bib28", "volume": "607", "year": "2022" }, { "DOI": "10.1016/S0140-6736(22)01938-9", "article-title": "WHO's therapeutics and COVID-19 living guideline on mAbs needs to be reassessed", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "2193", "journal-title": "Lancet", "key": "10.1016/j.jinf.2025.106510_bib29", "volume": "400", "year": "2022" }, { "DOI": "10.1016/j.ccell.2023.04.005", "article-title": "Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer", "author": "Wu", "doi-asserted-by": "crossref", "first-page": "821", "journal-title": "Cancer Cell", "key": "10.1016/j.jinf.2025.106510_bib30", "volume": "41", "year": "2023" }, { "article-title": "Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England", "author": "Harman", "journal-title": "Influenza Other Respir Virus", "key": "10.1016/j.jinf.2025.106510_bib31", "volume": "17", "year": "2023" }, { "DOI": "10.1186/s12879-024-09311-2", "article-title": "Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England", "author": "Patel", "doi-asserted-by": "crossref", "first-page": "428", "journal-title": "BMC Infect Dis", "key": "10.1016/j.jinf.2025.106510_bib32", "volume": "24", "year": "2024" }, { "article-title": "Effectiveness of sotrovimab and molnupiravir in community settings in England across the Omicron BA.1 and BA.2 sublineages: emulated target trials using the OpenSAFELY platform", "author": "Tazare", "journal-title": "medRxiv", "key": "10.1016/j.jinf.2025.106510_bib33", "year": "2023" }, { "article-title": "Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform", "author": "Zheng", "journal-title": "Lancet Reg Health Eur", "key": "10.1016/j.jinf.2025.106510_bib34", "volume": "34", "year": "2023" }, { "DOI": "10.1007/s15010-024-02245-6", "article-title": "Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review", "author": "Drysdale", "doi-asserted-by": "crossref", "first-page": "1839", "journal-title": "Infection", "key": "10.1016/j.jinf.2025.106510_bib35", "volume": "52", "year": "2024" }, { "DOI": "10.1007/s10875-023-01504-9", "article-title": "Persistent SARS-CoV-2 PCR positivity despite anti-viral treatment in immunodeficient patients", "author": "Chan", "doi-asserted-by": "crossref", "first-page": "1083", "journal-title": "J Clin Immunol", "key": "10.1016/j.jinf.2025.106510_bib36", "volume": "43", "year": "2023" } ], "reference-count": 37, "references-count": 37, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0163445325001045" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study", "type": "journal-article", "update-policy": "https://doi.org/10.1016/elsevier_cm_policy", "volume": "91" }